Instruction for use: Reserpine

Active substance: Reserpine

ATX Code C02AA02 Reserpine

Pharmacotherapeutic group:

sympatholytics

The nosological classification (ICD-10)

F29 Inorganic psychosis Unspecified

Childhood Psychosis, Psychomotor agitation in psychosis, Hallucinatory-delusional disorders, Hallucinatory-delusional syndrome, substance-induced psychosis, Manic-delusional disorders, Manic chronic psychosis, Manic psychosis, Acute psychosis, Paranoid psychosis, Subacute psychosis, presenile psychosis, Psychosis, Psychosis intoxication, paranoid psychosis, Psychosis in Children, Reactive psychosis, Chronic psychoses, Chronic hallucinatory psychosis, Chronic psychosis,Chronic Psychotic Disorder, schizophrenic psychosis

I10 Essential (primary) hypertension

Hypertension, Arterial hypertension, Arterial hypertension crisis course, Essential Hypertension

Primary hypertension, Arterial hypertension, complications of diabetes, hypertension, The sudden increase in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial Hypertension, malignant Hypertension, Hypertonic disease, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, The aggravation of hypertensive disease, Transient hypertension, Isolated systolic hypertension

I15 Secondary hypertension

Arterial hypertension, complications of diabetes, hypertension, The sudden rise in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial hypertension, malignant hypertension, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, hypertensive crisis, The aggravation of hypertensive disease, Transient hypertension, hypertension, Arterial hypertension, Arterial hypertension crisis course, renovascular hypertension, symptomatic hypertension, renal hypertension, Renovascular hypertension, Symptomatic hypertension

Structure and Composition

1 tablet contains reserpine 0.1 or 0.25 mg.

Indications

Arterial hypertension, mental illness vascular etiology, psychosis against the background of high blood pressure, hyperkinetic syndrome.

Contraindications

Hypersensitivity, depression, gastric ulcer and duodenal ulcer, ulcerative colitis, AV block, bradycardia, congestive heart failure.

Side effects

Hyperemia of the mucous membranes of eyes, nasal congestion, dry mucous membranes of the nose, dyspepsia, gastrointestinal ulceration of the mucous, bradycardia, weakness, dizziness, anxiety, depression, insomnia, shortness of breath, parkinsonism.

Dosing and Administration

Inside, the food, 0.1 mg 1-2 times a day with a gradual increase in the dose of 0.25-0.5 mg per day for 3-4 hours.

Storage conditions

In a cool, dark place.

Keep out of the reach of children.

shelf life

3 years.

Do not use beyond the expiration date printed on the package.